Citizens National Bank Trust Department’s Carnival Corporation Ltd CCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86K Hold
100
﹤0.01% 363
2026
Q1
$2.59K Hold
100
﹤0.01% 364
2025
Q4
$3.05K Hold
100
﹤0.01% 353
2025
Q3
$2.89K Hold
100
﹤0.01% 372
2025
Q2
$2.81K Hold
100
﹤0.01% 367
2025
Q1
$1.95K Hold
100
﹤0.01% 391
2024
Q4
$2.49K Hold
100
﹤0.01% 341
2024
Q3
$1.85K Hold
100
﹤0.01% 335
2024
Q2
$1.87K Hold
100
﹤0.01% 336
2024
Q1
$1.63K Hold
100
﹤0.01% 329
2023
Q4
$1.85K Hold
100
﹤0.01% 304
2023
Q3
$1.37K Hold
100
﹤0.01% 314
2023
Q2
$1.88K Hold
100
﹤0.01% 310
2023
Q1
$1.01K Hold
100
﹤0.01% 301
2022
Q4
$1K Hold
100
﹤0.01% 304
2022
Q3
$1K Buy
+100
New +$969 ﹤0.01% 318

Other funds holding CCL

Citizens National Bank Trust Department's CCL Position: Q2 2026 in Review

Citizens National Bank Trust Department held its Carnival Corporation Ltd (CCL) position steady in Q2 2026 at 100 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Citizens National Bank Trust Department first reported a position in CCL in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.05K in Q4 2025. 490 funds tracked by Wall St. Rank hold CCL as of Q2 2026.

  • Citizens National Bank Trust Department held 100 shares of Carnival Corporation Ltd worth $2.86K as of Q2 2026.
  • Citizens National Bank Trust Department left its Carnival Corporation Ltd share count unchanged in Q2 2026.
  • Carnival Corporation Ltd made up ﹤0.01% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #363 holding.
  • Citizens National Bank Trust Department first reported a position in Carnival Corporation Ltd in Q3 2022 and has held it in 16 quarters since.
  • Citizens National Bank Trust Department's Carnival Corporation Ltd position peaked at $3.05K in Q4 2025.
  • 490 funds tracked by Wall St. Rank held Carnival Corporation Ltd as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.